GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cano Health Inc (OTCPK:CANOQ) » Definitions » ROE %

Cano Health (Cano Health) ROE % : 0.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Cano Health ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Cano Health's annualized net income for the quarter that ended in Dec. 2023 was $-660 Mil. Cano Health's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $-235 Mil. Therefore, Cano Health's annualized ROE % for the quarter that ended in Dec. 2023 was N/A%.

The historical rank and industry rank for Cano Health's ROE % or its related term are showing as below:

CANOQ' s ROE % Range Over the Past 10 Years
Min: -1414.4   Med: -72.55   Max: -9.78
Current: -1414.4

During the past 5 years, Cano Health's highest ROE % was -9.78%. The lowest was -1,414.40%. And the median was -72.55%.

CANOQ's ROE % is ranked worse than
99.18% of 610 companies
in the Healthcare Providers & Services industry
Industry Median: 4.115 vs CANOQ: -1414.40

Cano Health ROE % Historical Data

The historical data trend for Cano Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cano Health ROE % Chart

Cano Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
- -143.20 -9.78 -72.55 -

Cano Health Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -180.08 -42.21 -263.35 -8,468.02 -

Competitive Comparison of Cano Health's ROE %

For the Medical Care Facilities subindustry, Cano Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cano Health's ROE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cano Health's ROE % distribution charts can be found below:

* The bar in red indicates where Cano Health's ROE % falls into.



Cano Health ROE % Calculation

Cano Health's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-594.418/( (252.631+-347.973)/ 2 )
=-594.418/-47.671
=N/A %

Cano Health's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-660.112/( (-122.098+-347.973)/ 2 )
=-660.112/-235.0355
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.


Cano Health  (OTCPK:CANOQ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-660.112/-235.0355
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-660.112 / 2864.112)*(2864.112 / 1112.835)*(1112.835 / -235.0355)
=Net Margin %*Asset Turnover*Equity Multiplier
=-23.05 %*2.5737*N/A
=ROA %*Equity Multiplier
=-59.32 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-660.112/-235.0355
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-660.112 / -1102.696) * (-1102.696 / -633.448) * (-633.448 / 2864.112) * (2864.112 / 1112.835) * (1112.835 / -235.0355)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.5986 * 1.7408 * -22.12 % * 2.5737 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Cano Health ROE % Related Terms

Thank you for viewing the detailed overview of Cano Health's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cano Health (Cano Health) Business Description

Traded in Other Exchanges
N/A
Address
9725 NW 117th Avenue, Suite 200, Miami, FL, USA, 33178
Cano Health Inc operates value-based primary care centers and supports affiliated medical practices that specialize in primary care for seniors in Florida, Texas, Nevada, and Puerto Rico.
Executives
Elliot Cooperstone director, 10 percent owner C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Eladio Gil officer: Interim CFO 9725 NW 17TH AVENUE, SUITE 200, MIAMI FL 33178
Robert Camerlinck officer: Chief Operating Officer 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Richard Aguilar officer: Chief Clinical Officer 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Mark D. Kent officer: Interim CEO 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
David J Armstrong officer: See Remarks 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Brian D Koppy officer: Chief Financial Officer 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Lewis Gold director 1235 SPANISH RIVER ROAD, BOCA RATON FL 33432
Marlow Hernandez director, officer: See Remarks 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Solomon D Trujillo director 1000 NICOLLET MALL, TPS-3255, MINNEAPOLIS MN 55403
Alan Muney director 48 MONROE TURNPIKE, TRUMBULL CT 06611
Kim M Rivera director 601 HAWAII ST, EL SEGUNDO CA 90245
Itc Rumba, Llc 10 percent owner 444 MADISON AVENUE, 35TH FLOOR, NEW YORK NY 10022
Jacqueline Guichelaar director C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178
Angel L Morales director C/O CANO HEALTH, INC., 9725 NW 117TH AVENUE, SUITE 200, MIAMI FL 33178